GlassScriptPhysician profile
Sean P Ryan
NPI 1891991402
$46,754.94
in general payments reported to CMS, 2019-2025
33 companies · $10K in 2025
The $10K reported for 2025 was more than what 90% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,221 · 2021: $3,370 · 2022: $1,979 · 2023: $5,007 · 2024: $11K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $22K · Food and Beverage: $4,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $21,944.44 |
| Food and Beverage | $4,589.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27,764.92 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Medtronic Vascular, INC. | $5,250.28 | 2019-2020 | |
| Cardiovascular Systems INC. | $4,150.69 | 2019-2022 | |
| Silk Road Medical, INC. | $2,114.33 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,782.31 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, C3 Delivery System, Gore Viabahn Vbx Balloon Expandable Endo |
| Cook Medical LLC | $1,375.69 | 2019-2025 | Zenith Spiral-Z, Cook Celect, Tornado |
| Boston Scientific Corporation | $1,127.40 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Angiography, Eluvia |
| Medtronic, INC. | $798.94 | 2021-2025 | Endurant Iis, Venaseal |
| Penumbra, INC. | $566.91 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $299.28 | 2019-2024 | Xarelto |
| Endologix LLC | $256.71 | 2023-2024 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Bard Peripheral Vascular, INC. | $252.30 | 2019-2024 | Venovo, Covera, Presto |
| Bolton Medical INC | $189.43 | 2021-2025 | Treo Abdominal Stent-Graft System |
| Artivion, INC. | $113.64 | 2020-2022 | |
| Sanara Medtech INC. | $107.38 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $89.60 | 2019 | |
| Edwards Lifesciences Corporation | $81.75 | 2019 | |
| Abbott Laboratories | $71.52 | 2019-2024 | Diamondback Peripheral, Hi-Torque Command, Armada |
| Amgen INC. | $55.36 | 2020-2022 | |
| Stryker Corporation | $52.38 | 2025 | Clottriever Bold Catheter |
| Lemaitre Vascular, INC. | $27.47 | 2022-2023 | Flexcel Carotid Shunt |
| Elutia, INC. | $26.10 | 2021 | |
| Becton, Dickinson and Company | $25.62 | 2022 | |
| Tactile Systems Technology INC | $23.88 | 2021 | |
| Inari Medical, INC. | $23.42 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medela LLC | $21.64 | 2021 | |
| Covidien LP | $19.19 | 2019 | |
| Kerecis Limited | $19.13 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Solventum Corporation | $18.33 | 2024 | 3m Coban, Promogran Prisma, Kerramax Care |
| Cardinal Health 200 LLC | $18.10 | 2020 | |
| Teleflex LLC | $13.43 | 2019 | |
| Lantheus Medical Imaging, INC. | $13.41 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.